risankizumab
abbvie
['crohn', 'risan']
b0378 part 2: fatigue improvement and workplace productivity/indirect costs with risankizumab in crohn s disease #acg2022 
I'm a Mayo specialist in evaluation and management of patients with ulcerative colitis and Crohn's disease. Tweets are mine. Retweet doesn't mean endorsement.